Terms: = Thyroid cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR
141 results:
1. Prevalence of thyroid diffuse goiter and its association with body mass index and the presence of cysts and nodules in children and adolescents: the Fukushima Health Management Survey.
Nakahata N; Asano M; Abe N; Ejiri H; Ota H; Suzuki S; Sato A; Tazaki R; Nagamine N; Takahashi C; Yamaya Y; Iwadate M; Matsuzuka T; Ohira T; Yasumura S; Suzuki S; Furuya F; Shimura H; Suzuki S; Yokoya S; Ohto H; Kamiya K
Endocr J; 2024 Apr; 71(4):383-393. PubMed ID: 38369332
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of the Therapeutic Efficacy and Technical Outcomes between Conventional Fixed Electrodes and Adjustable Electrodes in the Radiofrequency Ablation of Benign thyroid Nodules.
Shin JH; Seo M; Lee MK; Jung SL
Korean J Radiol; 2024 Feb; 25(2):199-209. PubMed ID: 38288899
[TBL] [Abstract] [Full Text] [Related]
3. The Establishment and Verification of a Nomogram Model for Predicting the Overall Survival of Medullary thyroid Carcinoma: An Analysis Based on the SEER Database.
Wang W; Wang X; Che G; Qiao J; Chen Z; Liu J
Curr Oncol; 2023 Dec; 31(1):84-96. PubMed ID: 38248091
[TBL] [Abstract] [Full Text] [Related]
4. Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
Xu T; Zhu C; Song F; Zhang W; Yuan M; Pan Z; Huang P
BMC Cancer; 2023 Nov; 23(1):1131. PubMed ID: 37990304
[TBL] [Abstract] [Full Text] [Related]
5. A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
Ho AL; Foster NR; Deraje Vasudeva S; Katabi N; Antonescu CR; Frenette GP; Pfister DG; Erlichman C; Schwartz GK
Cancer; 2024 Mar; 130(5):702-712. PubMed ID: 37947157
[TBL] [Abstract] [Full Text] [Related]
6. A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor activity of QL1604, a humanized anti-PD-1 mAb, in patients with advanced or metastatic solid tumors.
Huang Z; Xu Y; Hong W; Gong L; Chen K; Qin J; Xie F; Wang F; Tian X; Meng X; Feng W; Li L; Zhang B; Kang X; Fan Y
Front Immunol; 2023; 14():1258573. PubMed ID: 37936687
[TBL] [Abstract] [Full Text] [Related]
7. Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review.
Li P; Zhang Y; Xu T; Zhu J; Wei T; Zhao W
Nucl Med Commun; 2023 Dec; 44(12):1114-1125. PubMed ID: 37769014
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of progression-free survival as a surrogate endpoint for overall survival in locally advanced or metastatic differentiated thyroid cancer: a systematic review.
Yang S; Zhan J; Xu X
Endocrine; 2023 Dec; 82(3):491-497. PubMed ID: 37702900
[TBL] [Abstract] [Full Text] [Related]
9. Reticular fibre structure in the differential diagnosis of parathyroid neoplasms.
Hu X; He S; Jiang X; Wei P; Zhou X; Shi Z; Li X; Lu J; Zhao H; Wei B; Jin M
Diagn Pathol; 2023 Jul; 18(1):79. PubMed ID: 37403167
[TBL] [Abstract] [Full Text] [Related]
10. A Proposed Modified Staging System for Medullary thyroid cancer: A SEER Analysis With Multicenter Validation.
Wang Z; Fan X; Zha X; Xu Y; Yin Z; Rixiati Y; Yu F
Oncologist; 2024 Jan; 29(1):e59-e67. PubMed ID: 37311049
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of the cox regression to machine learning in predicting the survival of anaplastic thyroid carcinoma.
Xu L; Cai L; Zhu Z; Chen G
BMC Endocr Disord; 2023 Jun; 23(1):129. PubMed ID: 37291551
[TBL] [Abstract] [Full Text] [Related]
12. Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)-secreting pituitary adenomas.
Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
Clin Endocrinol (Oxf); 2023 Sep; 99(3):306-314. PubMed ID: 37144621
[TBL] [Abstract] [Full Text] [Related]
13. An Analysis of Environment-, Individual-, and Tumor-Related Factors Impacting Hypovitaminosis D in Patients with Malignant Tumors.
Bai Y; Wen YQ; Jiao Y; Zhang YH; Ma X
Nutr Cancer; 2023; 75(5):1340-1348. PubMed ID: 36988095
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and Safety of Minimally Invasive thyroid Surgery: A Network Meta-Analysis.
Kim DH; Kim SW; Kim GJ; Basurrah MA; Hwang SH
Laryngoscope; 2023 Oct; 133(10):2470-2479. PubMed ID: 36892037
[TBL] [Abstract] [Full Text] [Related]
15. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
[TBL] [Abstract] [Full Text] [Related]
16. Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center.
Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
Front Endocrinol (Lausanne); 2022; 13():1061029. PubMed ID: 36518240
[TBL] [Abstract] [Full Text] [Related]
17. Seroprevalence of Anti-Thyroglobulin Antibodies in Korea.
Choi R; Lee SG; Lee EH
Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250832
[TBL] [Abstract] [Full Text] [Related]
18. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
Front Public Health; 2022; 10():969030. PubMed ID: 36203704
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
[TBL] [Abstract] [Full Text] [Related]
20. A Risk Stratification Model for Metastatic Lymph Nodes of Papillary thyroid cancer: A Retrospective Study Based on Sonographic Features.
Ni X; Xu S; Zhan W; Zhou W
Front Endocrinol (Lausanne); 2022; 13():942569. PubMed ID: 35937798
[TBL] [Abstract] [Full Text] [Related]
[Next]
